InsiderTrades.com logo
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
From Smallcaps Daily   |   Ad
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Click to read

LMFA Insider Trading

Insider Ownership Percentage: 20.22%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $15,054.04

LM Funding America Insider Trading History Chart

This chart shows the insider buying and selling history at LM Funding America by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

LM Funding America Share Price & Price History

Current Price: $2.45
Price Change: ▲ Price Increase of +0.01 (0.41%)
As of 05/7/2024 01:00 AM ET

This chart shows the closing price history over time for LMFA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals   |   Ad
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold.

LM Funding America Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/24/2024Ryan H DuranVPSell500$2.83$1,415.0021,318View SEC Filing Icon  
4/10/2024Ryan H DuranVPSell500$3.27$1,635.0021,818View SEC Filing Icon  
3/27/2024Ryan H DuranVPSell500$2.92$1,460.0022,318View SEC Filing Icon  
2/28/2024Ryan H DuranVPSell500$3.42$1,710.0023,317View SEC Filing Icon  
1/31/2024Ryan H DuranVPSell500$3.06$1,530.0024,317View SEC Filing Icon  
1/17/2024Ryan H DuranVPSell500$2.94$1,470.0024,817View SEC Filing Icon  
1/3/2024Ryan H DuranVPSell500$3.72$1,860.0025,317View SEC Filing Icon  
9/18/2023Ryan H DuranCFOSell1,162$3.42$3,974.0425,920View SEC Filing Icon  
4/13/2023Andrew L GrahamDirectorBuy1,816$5.58$10,133.287,302View SEC Filing Icon  
6/14/2022Douglas I MccreeDirectorBuy833$5.46$4,548.18901View SEC Filing Icon  
6/9/2022Andrew L GrahamDirectorBuy1,533$6.42$9,841.865,486View SEC Filing Icon  
5/19/2022Andrew L GrahamDirectorBuy2,500$7.50$18,750.002,506View SEC Filing Icon  
See Full Table
AI “wealth window” is closing June 25th
From Paradigm Press   |   Ad
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
I put together this personal video [HERE]…

SEC Filings (Institutional Ownership Changes) for LM Funding America (NASDAQ:LMFA)

22.73% of LM Funding America stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LMFA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

LM Funding America Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/30/2023International Assets Investment Management LLC77,167$43K0.0%N/A0.590%Search for SEC Filing on Google Icon
1/24/2022National Bank of Canada FI18,175$88K0.0%N/A0.142%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC77,588$0.33M0.0%+6.4%1.433%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC38,384$0.16M0.0%-75.9%0.709%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.99,643$0.43M0.0%-60.7%1.840%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC53,418$69K0.0%N/A0.987%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC53,418$69K0.0%N/A0.990%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC72,931$94K0.0%+6.3%1.351%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp47,767$62K0.0%+264.4%0.885%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC159,059$0.21M0.0%+423.3%2.947%Search for SEC Filing on Google Icon
5/10/2021HighTower Advisors LLC26,100$34K0.0%N/A0.484%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC96,783$65K0.0%-14.3%0.628%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC68,600$46K0.0%N/A0.445%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC112,964$74K0.0%N/A0.734%Search for SEC Filing on Google Icon
8/14/2020Sabby Management LLC25,000$34K0.0%N/A0.490%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
LM Funding America logo
LM Funding America, Inc. operates as a cryptocurrency mining and technology-based specialty finance company. It engages in Bitcoin mining operations. The company also provides funding to nonprofit community associations primarily located in the state of Florida, as well as in the states of Washington, Colorado, and Illinois. The company was founded in 2008 and is based in Tampa, Florida.
Read More on LM Funding America

Today's Range

Now: $2.45
Low: $2.42
High: $2.68

50 Day Range

MA: $2.95
Low: $2.38
High: $3.66

52 Week Range

Now: $2.45
Low: $1.63
High: $8.22

Volume

54,778 shs

Average Volume

120,809 shs

Market Capitalization

$6.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of LM Funding America?

LM Funding America's top insider investors include:
  1. Ryan H Duran (CFO)
  2. Ryan H Duran (VP)
  3. Andrew L Graham (Director)
  4. Douglas I Mccree (Director)
Learn More about top insider investors at LM Funding America.
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
From Smallcaps Daily   |   Ad
See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.
Click to read